350 related articles for article (PubMed ID: 11403732)
1. Cotinine binding to nicotinic acetylcholine receptors in bovine chromaffin cell and rat brain membranes.
Vainio PJ; Tuominen RK
Nicotine Tob Res; 2001 May; 3(2):177-82. PubMed ID: 11403732
[TBL] [Abstract][Full Text] [Related]
2. Antagonism of nicotinic receptors of rat chromaffin cells by N,N, N-trimethyl-1-(4-trans-stilbenoxy)-2-propylammonium iodide: a patch clamp and ligand binding study.
Di Angelantonio S; Nistri A; Moretti M; Clementi F; Gotti C
Br J Pharmacol; 2000 Apr; 129(8):1771-9. PubMed ID: 10780985
[TBL] [Abstract][Full Text] [Related]
3. Time and brain region specific up-regulation of low affinity neuronal nicotinic receptors during chronic nicotine administration in mice.
Nuutinen S; Ahtee L; Tuominen RK
Eur J Pharmacol; 2005 May; 515(1-3):83-9. PubMed ID: 15894304
[TBL] [Abstract][Full Text] [Related]
4. Interaction of the catecholamine release-inhibitory peptide catestatin (human chromogranin A(352-372)) with the chromaffin cell surface and Torpedo electroplax: implications for nicotinic cholinergic antagonism.
Taupenot L; Mahata SK; Mahata M; Parmer RJ; O'Connor DT
Regul Pept; 2000 Nov; 95(1-3):9-17. PubMed ID: 11062327
[TBL] [Abstract][Full Text] [Related]
5. Identified spinal motoneurons of young rats possess nicotinic acetylcholine receptors of the heteromeric family.
Ogier R; Liu X; Tribollet E; Bertrand D; Raggenbass M
Eur J Neurosci; 2004 Nov; 20(10):2591-7. PubMed ID: 15548202
[TBL] [Abstract][Full Text] [Related]
6. Chronic nicotine administration does not increase nicotinic receptors labeled by [125I]epibatidine in adrenal gland, superior cervical ganglia, pineal or retina.
Dávila-García MI; Musachio JL; Kellar KJ
J Neurochem; 2003 Jun; 85(5):1237-46. PubMed ID: 12753083
[TBL] [Abstract][Full Text] [Related]
7. Surface and intracellular nicotinic receptors expressed in intact adrenal chromaffin cells: direct measurements using [3H]epibatidine.
Free RB; McKay DB
Brain Res; 2003 Jun; 974(1-2):60-9. PubMed ID: 12742624
[TBL] [Abstract][Full Text] [Related]
8. [3H]Epibatidine binding to bovine adrenal medulla: evidence for alpha3beta4* nicotinic receptors.
Free RB; Bryant DL; McKay SB; Kaser DJ; McKay DB
Neurosci Lett; 2002 Jan; 318(2):98-102. PubMed ID: 11796195
[TBL] [Abstract][Full Text] [Related]
9. Differential agonist inhibition identifies multiple epibatidine binding sites in mouse brain.
Marks MJ; Smith KW; Collins AC
J Pharmacol Exp Ther; 1998 Apr; 285(1):377-86. PubMed ID: 9536034
[TBL] [Abstract][Full Text] [Related]
10. Characterization of (+/-)(-)[3H]epibatidine binding to nicotinic cholinergic receptors in rat and human brain.
Houghtling RA; Dávila-García MI; Kellar KJ
Mol Pharmacol; 1995 Aug; 48(2):280-7. PubMed ID: 7651361
[TBL] [Abstract][Full Text] [Related]
11. Characterisation of the binding of [3H]methyllycaconitine: a new radioligand for labelling alpha 7-type neuronal nicotinic acetylcholine receptors.
Davies AR; Hardick DJ; Blagbrough IS; Potter BV; Wolstenholme AJ; Wonnacott S
Neuropharmacology; 1999 May; 38(5):679-90. PubMed ID: 10340305
[TBL] [Abstract][Full Text] [Related]
12. Ligand specificity of nicotinic acetylcholine receptors in rat spinal cord: studies with nicotine and cytisine.
Khan IM; Yaksh TL; Taylor P
J Pharmacol Exp Ther; 1994 Jul; 270(1):159-66. PubMed ID: 8035312
[TBL] [Abstract][Full Text] [Related]
13. Agonist-induced up-regulation of alpha4beta2 nicotinic acetylcholine receptors in M10 cells: pharmacological and spatial definition.
Whiteaker P; Sharples CG; Wonnacott S
Mol Pharmacol; 1998 May; 53(5):950-62. PubMed ID: 9584223
[TBL] [Abstract][Full Text] [Related]
14. Epibatidine binding sites and activity in the spinal cord.
Khan IM; Yaksh TL; Taylor P
Brain Res; 1997 Apr; 753(2):269-82. PubMed ID: 9125412
[TBL] [Abstract][Full Text] [Related]
15. ABT-594 [(R)-5-(2-azetidinylmethoxy)-2-chloropyridine]: a novel, orally effective analgesic acting via neuronal nicotinic acetylcholine receptors: I. In vitro characterization.
Donnelly-Roberts DL; Puttfarcken PS; Kuntzweiler TA; Briggs CA; Anderson DJ; Campbell JE; Piattoni-Kaplan M; McKenna DG; Wasicak JT; Holladay MW; Williams M; Arneric SP
J Pharmacol Exp Ther; 1998 May; 285(2):777-86. PubMed ID: 9580626
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological similarities between native brain and heterologously expressed alpha4beta2 nicotinic receptors.
Shafaee N; Houng M; Truong A; Viseshakul N; Figl A; Sandhu S; Forsayeth JR; Dwoskin LP; Crooks PA; Cohen BN
Br J Pharmacol; 1999 Nov; 128(6):1291-9. PubMed ID: 10578144
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological evaluation of a Br-76 analog of epibatidine: a potent ligand for studying brain nicotinic acetylcholine receptors.
Kassiou M; Bottlaender M; Loc'h C; Dolle F; Musachio JL; Coulon C; Ottaviani M; Dannals RF; Maziere B
Synapse; 2002 Aug; 45(2):95-104. PubMed ID: 12112402
[TBL] [Abstract][Full Text] [Related]
18. Diversity of nicotinic acetylcholine receptors in rat hippocampal neurons. III. Agonist actions of the novel alkaloid epibatidine and analysis of type II current.
Alkondon M; Albuquerque EX
J Pharmacol Exp Ther; 1995 Aug; 274(2):771-82. PubMed ID: 7543571
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of nicotinic responses by cotinine in bovine adrenal chromaffin cells.
Vainio PJ; Viluksela M; Tuominen RK
Pharmacol Toxicol; 1998 Nov; 83(5):188-93. PubMed ID: 9834966
[TBL] [Abstract][Full Text] [Related]
20. [3H]A-585539 [(1S,4S)-2,2-dimethyl-5-(6-phenylpyridazin-3-yl)-5-aza-2-azoniabicyclo[2.2.1]heptane], a novel high-affinity alpha7 neuronal nicotinic receptor agonist: radioligand binding characterization to rat and human brain.
Anderson DJ; Bunnelle W; Surber B; Du J; Surowy C; Tribollet E; Marguerat A; Bertrand D; Gopalakrishnan M
J Pharmacol Exp Ther; 2008 Jan; 324(1):179-87. PubMed ID: 17959745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
